🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

DOBERMANN - A 2x2 factorial RCT where STEMI patients with ORBI risk score >= 11 are randomized to Tocilizumab and/or Dobutamine vs. placebo. Outcome: Temporal changes in NTproBNP.

In spaceflight as in medicine (or physics), uncertainty is everywhere. The weather forecast for Artemis I Launch remains "90% favourable". If all other systems are go, watch the big step towards returning to the moon tomorrow wed at 7:04 CET nasa.gov/live. 🚀 #Artemis1

Join us at the #ACVC23 congress 🫀 youtube.com/watch?v=bp2U-x… Laust Obling Pablo Jorge Konstantin Krychtiuk Jakob Josiassen Joakim Bo Kunkel JakobHartvigThomsen Martin Frydland, MD, PhD Christian Hassager Christina Byrne Helle Søholm Hannah Schaubroeck Christophe Vandenbriele Frederik H. Verbrugge

Excited and privileged to discuss our ongoing DOBERMANN RCT with good colleagues from near and far today in Marseille at #ACVC2023 w/CRITICAL CARDIAC CARE RESEARCH GROUP

Thanks to The Collaboration of Young Researchers Foreningen af Yngre Forskere på Rigshospitalet for the opportunity to showcase some of my current research as part of CRITICAL CARDIAC CARE RESEARCH GROUP at Rigshospitalet. Congrats to competition winners and to FYF for a well executed event today!

On our way to #dcs2023 with Joakim Bo Kunkel Can't wait to see talented researchers present their data. Of course highlight of the year will be Laust Obling presenting novel data of cardiac arrest

A solid walkthrough of all aspects to be considered when treating and discharging patients admitted with decompensated heart failure. This and lots more lined up at DCS2023. Dansk Cardiologisk Selskab (DCS) CRITICAL CARDIAC CARE RESEARCH GROUP Martin Frydland, MD, PhD

Just out 📢❗️ Sex-and age-related variations in myocardial tissue composition of the healthy heart: A native T1 mapping cohort study by Katrine Myhr in EHJ Editor-in-Chief 👏 doi.org/10.1093/ehjci/…

Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t